Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF LEGAL OFFICER

CHIEF MEDICAL OFFICER

CHIEF COMMERCIAL OFFICER

CHIEF FINANCIAL OFFICER

PRESIDENT AND CEO

Chief Financial Officer

Chief Legal Officer

Chief Medical Officer

President and CEO

Chief Commercial Officer

Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing VP-315, an oncolytic peptide-based injectable therapy for the treatment of dermatology oncologic conditions, including basal cell carcinoma; and cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for dermatological oncology indications, including non-metastatic melanoma and non-metastatic Merkel cell carcinoma. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases i...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-15	Premium	acquired	Premium	Premium	Premium	CHIEF LEGAL OFFICER
2024-03-15	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-15	Premium	acquired	Premium	Premium	Premium	CHIEF COMMERCIAL OFFICER
2024-03-15	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-03-15	Premium	acquired	Premium	Premium	Premium	PRESIDENT AND CEO
2023-12-29	Premium	bought	Premium	Premium	Premium	-
2023-12-28	Premium	bought	Premium	Premium	Premium	-
2023-12-27	Premium	bought	Premium	Premium	Premium	-
2023-12-26	Premium	bought	Premium	Premium	Premium	-
2023-12-22	Premium	bought	Premium	Premium	Premium	-
2023-12-21	Premium	bought	Premium	Premium	Premium	-
2023-12-19	Premium	bought	Premium	Premium	Premium	-
2023-12-18	Premium	bought	Premium	Premium	Premium	-
2023-12-15	Premium	bought	Premium	Premium	Premium	-
2023-11-15	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-11-15	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-11-15	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-11-15	Premium	sold	Premium	Premium	Premium	President and CEO
2023-11-15	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-11-14	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-11-14	Premium	sold	Premium	Premium	Premium	President and CEO
2023-11-14	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-11-14	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-11-14	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-08-24	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

VRCA - Verrica Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for VRCA